SNHG1 is aberrantly expressed in a variety of cancers and participates as a tumor driver in the regulation of multiple processes such as cell proliferation,cycling,apoptosis,migration,and invasion,etc.SNHG1 has potential to become a new biomarker and therapeutic target for tumor diagnosis,treatment,and prognostic assessment.This article reviews latest research progress on the pathogenesis of SNHG1 and the role of SNHG1 in tumor genesis and development,with a view to providing a new basis and direction for early diagnosis and early treatment of tumors.